Traditionally, regulatory submissions are created with disparate systems
for content management and publishing. Working with separate systems
requires file transfers and impedes the publishing team’s visibility
into document readiness, making it difficult to effectively plan and
allocate resources.

“Submission planning, registration tracking, document management, and
publishing are all within one end-to-end process,” said Steve Gens,
managing partner at Gens and Associates. “Having publishing within a set
of unified regulatory capabilities can reduce cycle times and improve
productivity throughout the entire submission development process.”

Veeva Vault Submissions Publishing empowers publishing teams to perform
activities during document authoring, formatting, and reviews. This
enables a continuous publishing process instead of waiting for the
submission plan and documents to be finalized. With activities such as
document hyperlinking and validation now moved upstream and automated,
teams can complete work faster and speed submission development.

Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 475 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit www.veeva.com/eu
.

Forward-looking Statements

This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in the company’s filing on Form
10-Q for the period ended October 31, 2016. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov
.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.